Transaction · 0001062993-25-002744

ROBINS CHAD M

ROBINS CHAD M, CHAIR, reported an open-market or private sale at Adaptive Biotechnologies Corp involving 100287.000000 shares for an estimated $846422.28. Reported holdings after the transaction were 2576701.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR
ADPTAdaptive Biotechnologies Corp
Filing timeFeb 19
Trade dateFeb 13, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ADPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ADPT since 2025-02-19Filed 563 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001062993-25-002744
Common Stock
Transaction date
Feb 13, 2025
Filed Feb 19, 2025, 01:21 AM · 6d delay
Shares
100k sh
$844 per share
Estimated value
-$84.6M
Computed from shares × price
Holdings after
2.57M sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 6 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership 10b5-1 Detected
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and Chairman

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024. The option expires on June 9, 2025.

  2. F2

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.56, inclusive. The reporting person undertakes to provide to…

  3. F3

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.69, inclusive. The reporting person undertakes to provide to…

  4. F4

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.91, inclusive. The reporting person undertakes to provide to…

  5. F5

    The option is fully vested and exercisable.

Original filing · 0001062993-25-002744
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ADPT